Details
Title
An assessment model for efficacy of autologous CD19 chimeric antigen receptor T-cell therapy and relapse or refractory diffuse large B-cell lymphoma risk
Author
Xue Bin 1 ; Liu, Yifan 1 ; Zhang, Min 1 ; Xiao Gangfeng 2 ; Luo Xiu 1 ; Zhou, Lili 1 ; Ye Shiguang 1 ; Lu, Yan 1 ; Qian Wenbin 3 ; Wang, Li 4 ; Li, Ping 1 ; Liang Aibin 1
1 Department of Hematology, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China
2 Department of Hematology, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China; Department of Hematology, Ningbo No.2 Hospital, Ningbo, Zhejiang 315010, China
3 Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China
4 Department of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200001, China
1 Department of Hematology, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China
2 Department of Hematology, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China; Department of Hematology, Ningbo No.2 Hospital, Ningbo, Zhejiang 315010, China
3 Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China
4 Department of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200001, China
Pages
108-110
Section
Correspondence
Publication year
2025
Publication date
Jan 2025
ISSN
03666999
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3152787706
Copyright
Copyright © 2024 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.